Company / AR per Share
TEVA PHARMACEUTICAL INDUSTRIES LTD AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$3.31
FY2025
5-year range
$2.76 / $4.15
FY2021-FY2025
Trend
+20.3%
vs FY2024
Sector context
#30 of 115
Health Care
What the data says
At $3.31, TEVA PHARMACEUTICAL INDUSTRIES LTD's ar per share ranks #30 of 115 in the Health Care sector. AR per Share returned to growth in FY2025 after 6 years of decline, reaching $3.31.
Based on SEC 10-K filings.
3.31 in FY2025 with a 5-year CAGR of -5.9%.
Improved from $3.08 to $3.31 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- -0.6%
- 5-Year CAGR
- -5.9%
- 10-Year CAGR
- -
Sector benchmark
#30 of 115 in Health CareTop 26% of 115This company $3.31 Sector average $27.05
▼
-87.7% below sector average
Key checks
Key Insights
- In FY2025, ar per share increased 20.3% year-over-year.
- Ranks #30 out of 115 companies in the Health Care sector.
- Peak ar per share was recorded in FY2016.
- Lowest ar per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.31 | +20.3% |
| FY2024 | $2.76 | -10.5% |
| FY2023 | $3.08 | -8.8% |
| FY2022 | $3.38 | -18.7% |
| FY2021 | $4.15 | -7.5% |
| FY2020 | $4.49 | -19.7% |
| FY2019 | $5.59 | -100.0% |
| FY2018 | $6058272.63 | +86352383.1% |
| FY2017 | $7.02 | -100.0% |
| FY2016 | $7828303.85 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026